
The researchers noted that athletes in endurance sports were twice as likely to carry the genetic variant compared to non-athletes.
Photo Credit: Quan-You Zhang
Scientific Frontline: "At a Glance" Summary
- Main Discovery: The gene RAB3GAP2 has been identified as a regulatory "brake" on the formation of new blood vessels in muscles, where its suppression directly stimulates capillary growth and enhances endurance.
- Methodology: Researchers analyzed muscle tissue and genomic data from over 600 individuals, comparing elite endurance athletes, sprinters, and non-athletes to isolate genetic markers linked to capillary density and training responses.
- Key Data: Elite endurance athletes, specifically cross-country skiers, were found to be twice as likely to carry the favorable genetic variant, with a prevalence of approximately 10% compared to only 5% in the non-athletic population.
- Significance: This mechanism controls the supply of oxygen and nutrients to muscle cells, providing a molecular explanation for how high-intensity training improves metabolic health by structurally adapting muscle tissue.
- Future Application: Insights from this study are currently being applied to develop personalized training programs, rehabilitation protocols, and pharmaceutical inhibitors to treat muscle insulin resistance in diabetic patients.
- Branch of Science: Genetics and Exercise Physiology
- Additional Detail: The variant promoting rapid vessel growth entails a physiological trade-off, as it is simultaneously linked to an increased inflammatory response and a higher susceptibility to muscle injuries.
.jpg)


.jpg)



.jpg)

.jpg)



